CombiMatrix, Sequenom announce collaboration

CombiMatrix (CBMX) and Sequenom (SQNM) enter into an agreement to collaborate on the promotion and marketing of "chromosomal microarray analysis testing services to broaden and confirm the results of noninvasive, prenatal testing."

The companies will provide physicians with "technical training" and plan to offer "counseling, education and support services to [both] physicians and their patients."